23andMe Holding Co. Stock News

The top Republican on the U.S. Senate's health committee has called on the chief executive of 23andMe to provide the panel with details after data from the family genetics website was advertised for s

The same hacker who leaked a trove of user data stolen from the genetic testing company 23andMe two weeks ago has now leaked millions of new user records.

23andMe, the DNA testing company, has fallen victim to a security breach after a hacker gained access and stole the personal genetic information of customers. Users were alerted about the hack after s

23andMe, the DNA testing company, has fallen victim to a security breach after a hacker gained access and stole the personal genetic information of customers. Users were alerted about the hack after s

23andMe said that the profile information of some customers was accessed without their permission by a third party.

Genetic testing company 23andMe has been investigating a security incident after hackers advertised a trove of alleged stolen user data on a hacking forum last week. But the alleged stolen data may ha

Federal law enforcement is now involved and third-party forensic experts are helping with the investigation, according to the company.

Days after user personal surfaced online, the genetic testing company 23andMe said it's requiring all users to reset their passwords “out of caution.” On Friday, 23andMe confirmed that hackers had

Okta CEO Todd McKinnon reacts to the data leakage of 23andMe users on 'The Claman Countdown.'

User data from 23andMe accounts has been leaked and put up for sale on a dark web forum. Hackers likely gathered the data with leaked customer credentials for other platforms and services.

The company, which has launched an investigation into the attack, said Friday it could not yet confirm whether the leaked information is real.

A hacker is advertising millions of "pieces of data" stolen from the family genetics websites 23andMe, according to posts made to an online forum where digital thieves often advertise leaked data.

Shares of 23andMe Holding Co. ME, -4.35% jumped 23% in the extended session Thursday after the genetics and biopharmaceutical company said that the U.S. Food and Drug Administration has cleared it to

510(k) clearance will allow 23andMe to report an additional 41 genetic variants in the BRCA1 and BRCA2 genes that increase risk for breast, ovarian, prostate and pancreatic cancer

AI for drug development is very fashionable in biotech, and for good reason. 23andMe's consumer business could one day provide a bedrock of stability.